Contact Now
Please Leave Us A Message
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shaanxi Kaishi Biotechnology Co., Ltd
$50
1-199 Others
$40
200-499 Others
$30
≥500 Others
Product Description
Docetaxel 99% is a high-purity pharmaceutical active pharmaceutical ingredient (API) widely used in oncology drug manufacturing and sterile injectable formulations. As a semi-synthetic taxane compound, it plays a critical role in modern chemotherapy drug development and regulated pharmaceutical supply chains.
With increasing global demand for advanced Pharmaceutical Enzymes, Nutritional Ingredients, and oncology-grade APIs, Docetaxel 99% remains a key compound for Supplement Contract Manufacturing, CDMO, and GMP-certified pharmaceutical production.
Content Note: Prepared by our technical team based on peer-reviewed scientific literature. All descriptions are intended for industrial and research use only and comply with FDA/EFSA communication guidelines. Last reviewed: June 2026
According to a study in Journal of Clinical Oncology (2004), docetaxel-based chemotherapy demonstrated significantly improved response rates in patients with advanced breast cancer compared to standard regimens.
According to a study in The Lancet Oncology (2008), docetaxel combination therapy showed meaningful clinical benefits in non-small cell lung cancer, supporting its role in first-line treatment protocols.
Docetaxel 99% is manufactured under strict GMP-controlled environments to ensure consistent purity, stability, and pharmaceutical compliance.
| Parameter | Specification |
|---|---|
| Active Ingredient | Docetaxel |
| Purity | ≥ 99% |
| Appearance | White to off-white powder |
| Test Method | HPLC |
| Form | Sterile API / Injectable intermediate |
| Storage | 2–8°C, protected from light and moisture |
The quality of Docetaxel 99% depends on synthesis pathway, purification technology, and sterile processing systems. Advanced manufacturing ensures compliance with global pharmaceutical standards.
| Production Stage | Quality Impact |
|---|---|
| Semi-synthetic extraction process | Maintains molecular stability and bioactivity |
| Multi-stage chromatographic purification | Reduces impurities and improves safety profile |
| Sterile freeze-drying technology | Enhances long-term stability for injectable use |
| API | Mechanism | Application Area |
|---|---|---|
| Docetaxel | Microtubule stabilization | Breast, lung, prostate cancers |
| Paclitaxel | Microtubule inhibition | Broad-spectrum chemotherapy |
| Doxorubicin | DNA intercalation | Solid tumors and hematologic cancers |
Docetaxel 99% is primarily used in oncology drug manufacturing and pharmaceutical formulation development.
It is also applied in research related to Plant Extracts , Standardized Extracts, Herbal Extracts , Antioxidants , and Superfood Powders in broader pharmaceutical innovation and formulation studies.
We supply Docetaxel 99% under strict pharmaceutical-grade quality systems with full regulatory support for global markets.
It is used as a pharmaceutical API in chemotherapy drug production for oncology applications.
Yes, it is widely processed into sterile injectable drugs under GMP conditions.
The standard purity is ≥99%, confirmed by HPLC analytical testing.
It should be stored at 2–8°C in a dry, light-protected environment.
Yes, OEM and contract manufacturing support is available for global pharmaceutical clients.
Packaging & Delivery
The file is encrypted. Please fill in the following information to continue accessing it
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.